We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Placebos in Trials of Monotherapy Lipid Disorder Drugs No Longer OK: EMA
Placebos in Trials of Monotherapy Lipid Disorder Drugs No Longer OK: EMA
The European Medicines Agency says it’s no longer acceptable for sponsors to conduct placebo-controlled clinical trials when developing monotherapy drugs for lipid disorders.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor